• Transaction values YS Biopharma at pre-money equity value of $834 million • Certain investors (“Forward Purchase Investors”) are expected to invest $30 million in a private placement concurrently...
Beijing, China – September 8, 2022 – YishengBio Co., Ltd., (“YishengBio”), a biopharmaceutical company dedicated to discovery, development, manufacturing and commercialization of new generations of vaccines and therapeutic biologics,...